Moxibustion for alleviating abdominal pain and distension in IBS-D patients: a randomized, controlled trial

ABSTRACT: Interventions: Patients in the treatment group were treated by moxibustion therapy once every other day, 3 times a week for 6 weeks in total. Moxa rolls provided by Nanyang Chinese Medicine Airong Co. LTD (Henan, China) were used in the trial. Points of Shenque (CV 8), Tianshu (ST25), and Zusanli (ST36) were selected for moxibustion in the supine position.;Experimental Other;moxibustion therapy Primary outcome(s): IBS-SSS from week 0 to week 6 6 weeks changes in total IBS-SSS from week 0 to week 6

DISEASE(S): Moxibustion, Ibs-d, Rct, Ibs-sss, Abdominal Pain,Diarrhea Irritable Bowel Syndrome (ibs-d) Was The Most Common Subtype In China, And Currently There Was No Effective Cure. Moxibustion Plays An Important Role In The Traditional Medical Systems Of China, And It Has Been Promoted For A Wide Variety Of Conditions, Such As Urinary Retention, Pain, Cancer, Stroke, Constipation, And Hypertension. However, Most Researches Of Moxibustion On Ibs Were Generally Of Low Quality And The Application Of Moxibustion Still Lack Of High Quality Evidence. We Conducted A Randomized, Controlled, Prospective Study To Observe Whether Moxibustion Could Effectively Improve The Symptoms Of Abdominal Pain, Abdominal Distension In Ibs-d Patients

PROVIDER: 27658 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR